HEMODIALYSIS AND HEMOPERFUSION FOR TREATMENT OF VALPROIC ACID AND GABAPENTIN POISONING

Citation
Mc. Fernandez et al., HEMODIALYSIS AND HEMOPERFUSION FOR TREATMENT OF VALPROIC ACID AND GABAPENTIN POISONING, Veterinary and human toxicology, 38(6), 1996, pp. 438-443
Citations number
34
Categorie Soggetti
Toxicology,"Veterinary Sciences
ISSN journal
01456296
Volume
38
Issue
6
Year of publication
1996
Pages
438 - 443
Database
ISI
SICI code
0145-6296(1996)38:6<438:HAHFTO>2.0.ZU;2-E
Abstract
A 31-y-old epileptic man developed coma and shock after suicidally ing esting large amounts of valproic acid and gabapentin. His peak valproi c acid level was 1306.9 mu g/mL (therapeutic range = 30-100 mu g/mL). His peak gabapentin level was 60.0 mu g/mL (therapeutic range = 2.0-8. 0 mu g/mL). his hypotension was refractory to crystalloid and presser infusions, but resolved during concurrent hemoperfusion and hemodialys is to enhance elimination of valproic acid. Concurrent hemoperfusion a nd hemodialysis, In series, produced a maximum valproic acid plasma cl earance of 55.4 mL/min versus a maximum reported intrinsic valproic ac id plasma clearance of 10.6 mL/min. Concurrent hemoperfusion and hemod ialysis, in series, should be considered in hemodynamically unstable p atients with valproic acid poisoning whose clinical condition is worse ning in spite of aggressive supportive care.